An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®).
Clinical trial NCT01871194 · COMPLETED
Trial details
- NCT number
- NCT01871194
- Sponsor
- Professor Saad Shakir
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-05-01
- Primary completion
- 2016-01-01
- Enrollment
- 3400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.